Krensavage Asset Management, LLC / BMRN
Krensavage Asset Management, LLC’s Biomarin Pharmaceutical Inc Position
Does Krensavage Asset Management, LLC own Biomarin Pharmaceutical Inc (BMRN)? Yes — 524.8K shares worth $30M (+11.59% of its 13F portfolio) as of Q1 2026.
Position Value
$30M
Q1 2026
Shares
524.8K
% of Portfolio
+11.59%
Quarters Held
3
currently held
Position History BMRN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Krensavage Asset Management, LLC’s full portfolio or all institutional holders of BMRN.